Effectiveness of subcutaneous monoclonal antibody treatment in emergency department outpatients with COVID‐19
Abstract Objectives To evaluate whether subcutaneous neutralizing monoclonal antibody (mAb) treatment given in the emergency department (ED) setting was associated with reduced hospitalizations, mortality, and severity of disease when compared to nontreatment among mAb‐eligible patients with coronav...
Saved in:
| Main Authors: | Sarah K. Wendel, Adane F. Wogu, Nichole E. Carlson, Laurel Beaty, Tellen D. Bennett, Kelly Bookman, David A. Mayer, Sean S. Michael, Kyle C. Molina, Jennifer L. Peers, Seth Russell, Richard D. Zane, Adit A. Ginde |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-02-01
|
| Series: | Journal of the American College of Emergency Physicians Open |
| Online Access: | https://doi.org/10.1002/emp2.13116 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experiences of recently diagnosed urban COVID-19 outpatients: A survey on patient worries, provider-patient interactions, and neutralizing monoclonal antibody treatment.
by: Lindsey E Fish, et al.
Published: (2025-01-01) -
Experiences of recently diagnosed urban COVID-19 outpatients: A survey on patient worries, provider-patient interactions, and neutralizing monoclonal antibody treatment
by: Lindsey E. Fish, et al.
Published: (2025-01-01) -
Immune regulatory adjuvant approach to mitigate subcutaneous immunogenicity of monoclonal antibodies
by: Nicole L. Jarvi, et al.
Published: (2024-12-01) -
Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume
by: M. Desai, et al.
Published: (2023-12-01) -
Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature
by: Eric Wierda, et al.
Published: (2020-06-01)